A Dose-Schedule Finding Design for Phase I-Ii Clinical Trials

Journal of the Royal Statistical Society. Series C: Applied Statistics - United Kingdom
doi 10.1111/rssc.12113
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

A Bayesian Dose Finding Design for Oncology Clinical Trials of Combinational Biological Agents

Journal of the Royal Statistical Society. Series C: Applied Statistics
UncertaintyStatisticsProbability
2013English

A Bayesian Dose-Finding Design for Drug Combination Clinical Trials Based on the Logistic Model

Pharmaceutical Statistics
StatisticsProbabilityPharmacology
2014English

A Bayesian Dose Finding Design for Clinical Trials Combining a Cytotoxic Agent With a Molecularly Targeted Agent

Journal of the Royal Statistical Society. Series C: Applied Statistics
UncertaintyStatisticsProbability
2014English

Two Stage Adaptive Optimal Design With Applications to Dose-Finding Clinical Trials

English

Isotonic Design for Phase I Clinical Trials: Can We Improve Further?

Austrian Journal of Statistics
UncertaintyApplied MathematicsStatisticsProbability
2019English

Effective Sample Size for Computing Prior Hyperparameters in Bayesian Phase I–II Dose-Finding

Clinical Trials
MedicinePharmacology
2014English

Operating Characteristics of Restrictions on Skipping Dose Level for Adaptive Dose-Finding Method in Two-Agent Phase I Trials

Japanese Journal of Biometrics
2015English

Comments on ‘Competing Designs for Drug Combination in Phase I Dose-Finding Clinical Trials’ by M-K. Riviere, F. Dubois, S. Zohar

Statistics in Medicine
EpidemiologyStatisticsProbability
2014English

A Dynamic Stopping Rule for Phase I Clinical Trials

Biometrical Letters
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy